ASND Ascendis Pharma A/S
Healthcare · Market cap: $17.1B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $284.4K | $4.6M |
| 2026-Q3 | $492.7K | $872.9K |
| 2026-Q4 | $0 | $0 |
Bought$777.1K5 buy days
Sold$5.5M3 sell days
Net insider flow-$4.7Mnet selling · 5 years
Latest trade2026-09-08Bodenhoff Mads
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | Sell | Bodenhoff Mads | EVP / SVP | 3,000 | $270.19 | $810.6K | 1 |
| 2026-09-02 | Sell | HOLTUG LARS | Director | 236 | $264.13 | $62.3K | 1 |
| 2026-08-14 | Buy | BIENAIME JEAN JACQUES | Director | 2,000 | $246.33 | $492.7K | 2 |
| 2026-06-02 | Buy | SMITH SCOTT THOMAS | CFO | 100 | $219.00 | $21.9K | 1 |
| 2026-05-29 | Buy | BIENAIME JEAN JACQUES | Director | 500 | $223.12 | $111.6K | 3 |
| 2026-05-29 | Buy | SMITH SCOTT THOMAS | CFO | 250 | $223.32 | $55.8K | 1 |
| 2026-05-26 | Buy | BIENAIME JEAN JACQUES | Director | 400 | $237.81 | $95.1K | 2 |
| 2026-05-11 | Sell | JENSEN FLEMMING STEEN | Other officer | 19,460 | $238.49 | $4.6M | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| JENSEN FLEMMING STEEN | Other officer | $0 | $4.6M | 2026-05-11 |
| Bodenhoff Mads | EVP / SVP | $0 | $810.6K | 2026-09-08 |
| BIENAIME JEAN JACQUES | Director | $699.3K | $0 | 2026-08-14 |
| SMITH SCOTT THOMAS | CFO | $77.7K | $0 | 2026-06-02 |
| HOLTUG LARS | Director | $0 | $62.3K | 2026-09-02 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.